Skip to main content

Advertisement

Log in

Renal angiomyolipomatosis and Kaposi’s sarcoma: a possible link disrupted by sirolimus

  • CE - LETTER TO THE EDITOR
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Taveira-DaSilva AM, Steagall WK, Moss J (2006) Lymphangioleiomyomatosis. Cancer Control 13:276–285

    PubMed  Google Scholar 

  2. Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G (2005) Sirolimus for Kaposi’s sarcoma in renal transplant recipients. N Engl J Med 352:1317–1323

    Article  PubMed  CAS  Google Scholar 

  3. Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, Schmithorst VJ, Laor T, Brody AS, Bean J, Salisbury S, Franz DN (2008) Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 358:140–151

    Article  PubMed  CAS  Google Scholar 

  4. McCormack FX, Inoue Y, Moss J et al; for the National Institutes of Health Rare Lung Diseases Consortium and the MILES Trial Group (2011) Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364:1595–1606

    Google Scholar 

  5. Sodhi A, Montaner S, Patel V, Gómez-Román JJ, Li Y, Sausville EA, Sawai ET, Gutkind JS (2004) Akt plays a central role in sarcomagenesis induced by Kaposi’s sarcoma herpesvirus-encoded G protein-coupled receptor. Proc Natl Acad Sci USA 6:4821–4826

    Article  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Grandaliano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stallone, G., Infante, B., Tartaglia, L. et al. Renal angiomyolipomatosis and Kaposi’s sarcoma: a possible link disrupted by sirolimus. Intern Emerg Med 7 (Suppl 2), 127–129 (2012). https://doi.org/10.1007/s11739-012-0833-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-012-0833-6

Keywords

Navigation